(Q39980036)

16 September 2017

0 references

Nonspecific interstitial pneumonitis after bortezomib and thalidomide treatment in a multiple myeloma patient (English)

1 reference

16 September 2017

0 references

5

Joon Chang

1 reference

16 September 2017

6

Moo Suk Park

1 reference

16 September 2017

4

Sung Kyu Kim

1 reference

16 September 2017

Wonseok Kang

1

1 reference

16 September 2017

Jin Seok Kim

series ordinal

2

1 reference

16 September 2017

Sang Ho Cho

series ordinal

3

1 reference

16 September 2017

1 May 2010

1 reference

16 September 2017

Yonsei Medical Journal

1 reference

16 September 2017

51

1 reference

16 September 2017

3

1 reference

16 September 2017

448-450

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

16 September 2017

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Emerging drugs in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852803

The emerging role of novel therapies for the treatment of relapsed myeloma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852803

Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852803

Pulmonary toxicity from novel antineoplastic agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852803

Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852803

Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852803

Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852803

10.3349/YMJ.2010.51.3.448

20 August 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference

16 September 2017

PubMed publication ID

20376900

1 reference